0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing spondylitis" gave back 110 results.
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Humira Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it is expected to grow at...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Aciclofenac is a new, strong antipyretic, analgesic, anti-arthritis drugs, clinically applicable to the treatment of rheumatoid arthritis, rheumatoid...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global PDE 4 Inhibitors market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Autoimmune Drugs market size was valued at US$ 2193.5 million in 2023. With growing demand in downstream market, the Autoimmune Drugs is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Etoricoxib Intermediate market size was valued at US$ million in 2023. With growing demand in downstream market, the Etoricoxib...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Rheumatology Therapeutics market size was valued at US$ 45350 million in 2023. With growing demand in downstream market, the Rheumatology...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global PDE 4 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
